12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Tuesday's intraday session, several healthcare stocks experienced significant movements. LianBio, TransCode Therapeutics, ImmunityBio, Ambrx Biopharma, Universe Pharmaceuticals, and Comera Life Sciences saw their shares increase by 128.1%, 45.24%, 27.92%, 25.47%, 24.05%, and 20.08% respectively. On the other hand, LumiraDx, INVO Bioscience, Sonoma Pharmaceuticals, Avenue Therapeutics, Brainstorm Cell, and Tempest Therapeutics saw their shares decline by 43.5%, 34.91%, 18.63%, 16.51%, 15.19%, and 14.96% respectively.
October 24, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Avenue Therapeutics shares declined by 16.51% during Tuesday's intraday session.
The significant decrease in Avenue Therapeutics' share price is likely to have a negative short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Brainstorm Cell shares declined by 15.19% during Tuesday's intraday session.
The significant decrease in Brainstorm Cell's share price is likely to have a negative short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
INVO Bioscience shares declined by 34.91% during Tuesday's intraday session.
The significant decrease in INVO Bioscience's share price is likely to have a negative short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
LumiraDx shares declined by 43.5% during Tuesday's intraday session.
The significant decrease in LumiraDx's share price is likely to have a negative short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Sonoma Pharmaceuticals shares declined by 18.63% during Tuesday's intraday session.
The significant decrease in Sonoma Pharmaceuticals' share price is likely to have a negative short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Tempest Therapeutics shares declined by 14.96% during Tuesday's intraday session.
The significant decrease in Tempest Therapeutics' share price is likely to have a negative short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Ambrx Biopharma shares increased by 25.47% during Tuesday's intraday session.
The significant increase in Ambrx Biopharma's share price is likely to have a positive short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Comera Life Sciences shares increased by 20.08% during Tuesday's intraday session.
The significant increase in Comera Life Sciences' share price is likely to have a positive short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
ImmunityBio shares increased by 27.92% during Tuesday's intraday session.
The significant increase in ImmunityBio's share price is likely to have a positive short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
LianBio shares increased by 128.1% during Tuesday's intraday session.
The significant increase in LianBio's share price is likely to have a positive short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
TransCode Therapeutics shares increased by 45.24% during Tuesday's intraday session.
The significant increase in TransCode Therapeutics' share price is likely to have a positive short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Universe Pharmaceuticals shares increased by 24.05% during Tuesday's intraday session.
The significant increase in Universe Pharmaceuticals' share price is likely to have a positive short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100